Abstract
Non-nervous systems particularly endocrine and immune systems interact with the nervous system. As a result, nervous system-related features favorably sensory perception can be found in as well as out of the nervous tissues.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Stansbury K, Gunnar MR. Adrenocortical activity and emotion regulation. Monogr Soc Res Child Dev. 1994;59(2–3):108–34.
Blalock JE. The immune system as a sensory organ. J Immunol. 1984;132(3):1067–70.
Blalock JE. The immune system as the sixth sense. J Intern Med. 2005;257(2):126–38.
Blalock JE, Smith EM. Conceptual development of the immune system as a sixth sense. Brain Behav Immun. 2007;21(1):23–33.
Blalock JE. A molecular basis for bidirectional communication between the immune and neuroendocrine systems. Physiol Rev. 1989;69(1):1–32.
Beishuizen A, Thijs LG. Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis. J Endotoxin Res. 2003;9(1):3–24.
Besedovsky H, et al. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science. 1986;233(4764):652–4.
Besedovsky H, et al. Short papers. Eur J Immunol. 1977;7(5):323–5.
Banks WA. Blood-brain barrier transport of cytokines: a mechanism for neuropathology. Curr Pharm Des. 2005;11(8):973–84.
Johnson AK, Gross PM. Sensory circumventricular organs and brain homeostatic pathways. FASEB J. 1993;7(8):678–86.
Breder CD, Dinarello CA, Saper CB. Interleukin-1 immunoreactive innervation of the human hypothalamus. Science. 1988;240(4850):321–4.
Breder CD, et al. Regional induction of tumor necrosis factor alpha expression in the mouse brain after systemic lipopolysaccharide administration. Proc Natl Acad Sci. 1994;91(24):11393.
Meisel C, et al. Central nervous system injury-induced immune deficiency syndrome. Nat Rev Neurosci. 2005;6(10):775.
Tracey KJ. The inflammatory reflex. Nature. 2002;420(6917):853.
Jansen ASP, et al. Central command neurons of the sympathetic nervous system: basis of the fight-or-flight response. Science. 1995;270(5236):644–6.
Woiciechowsky C, et al. Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat Med. 1998;4(7):808.
Gleeson M, et al. The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nat Rev Immunol. 2011;11(9):607.
Chrousos GP. The hypothalamic–pituitary–adrenal axis and immune-mediated inflammation. N Engl J Med. 1995;332(20):1351–63.
Barnes PJ. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci. 1998;94(6):557–72.
Gaykema RP, Dijkstra I, Tilders FJ. Subdiaphragmatic vagotomy suppresses endotoxin-induced activation of hypothalamic corticotropin-releasing hormone neurons and ACTH secretion. Endocrinology. 1995;136(10):4717–20.
Arnason BG, et al. Mechanisms of action of adrenocorticotropic hormone and other melanocortins relevant to the clinical management of patients with multiple sclerosis. Mult Scler (Houndmills, Basingstoke, England). 2013;19(2):130–6.
Wang H, et al. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med. 2004;10(11):1216.
Ulloa L. The vagus nerve and the nicotinic anti-inflammatory pathway. Nat Rev Drug Discov. 2005;4(8):673.
Jonge WJ, Ulloa L. The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation. Br J Pharmacol. 2009;151(7):915–29.
Sopori M. Effects of cigarette smoke on the immune system. Nat Rev Immunol. 2002;2(5):372.
Alkondon M, et al. Choline is a selective agonist of α7 nicotinic acetylcholine receptors in the rat brain neurons. Eur J Neurosci. 1997;9(12):2734–42.
Bencherif M, et al. Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases. Cell Mol Life Sci. 2011;68(6):931–49.
Martin LF, Kem WR, Freedman R. Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia. Psychopharmacology. 2004;174(1):54–64.
Kem WR. The brain α7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer’s disease: studies with DMXBA (GTS-21). Behav Brain Res. 2000;113(1–2):169–81.
Borovikova LV, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature. 2000;405(6785):458.
Zhang Y, et al. Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing modelclinical perspective. Circ Heart Fail. 2009;2(6):692–9.
Bonaz B, et al. Chronic vagus nerve stimulation in Crohn’s disease: a 6-month follow-up pilot study. Neurogastroenterol Motil. 2016;28(6):948–53.
Koopman FA, et al. Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis. Proc Natl Acad Sci. 2016;113(29):8284–9.
Mauskop A. Vagus nerve stimulation relieves chronic refractory migraine and cluster headaches. Cephalalgia. 2005;25(2):82–6.
Rush AJ, et al. Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study∗. Biol Psychiatry. 2000;47(4):276–86.
Wernicke JF, Terry Jr RS, Baker Jr RG. Treatment of eating disorders by nerve stimulation. 1993, Google Patents.
Wernicke JF, Terry Jr RS. Treatment of endocrine disorders by nerve stimulation. 1993, Google Patents.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Saghazadeh, A., Rezaei, N. (2019). The Sixth Sense Organs: The Immune System. In: Rezaei, N., Saghazadeh, A. (eds) Biophysics and Neurophysiology of the Sixth Sense. Springer, Cham. https://doi.org/10.1007/978-3-030-10620-1_20
Download citation
DOI: https://doi.org/10.1007/978-3-030-10620-1_20
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-10619-5
Online ISBN: 978-3-030-10620-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)